Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SolarEdge
SEDG
|
+$41.5M |
| 2 |
Illumina
ILMN
|
+$40.9M |
| 3 |
QuidelOrtho
QDEL
|
+$34.1M |
| 4 |
CIVI
Civitas Resources
CIVI
|
+$18.5M |
| 5 |
FMC
FMC
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$245M |
| 2 |
Apple
AAPL
|
+$85.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$56.2M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$40.7M |
| 5 |
Corpay
CPAY
|
+$40.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.91% |
| 2 | Consumer Discretionary | 12.94% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 8.9% |
| 5 | Industrials | 7.1% |
Similar funds
Invenomic Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Invenomic Capital Management held 204 positions worth $2.19B, down 7.9% from $2.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Invenomic Capital Management withdrew a net $471M in Q4 2023, closing 32 positions and reducing 88 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $245M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Invenomic Capital Management opened a new position in SolarEdge worth $42.6M.
- Invenomic Capital Management's largest Q4 2023 buy was SolarEdge: 455,600 shares worth $42.6M.
- Invenomic Capital Management added most to IPG Photonics in Q4 2023, an estimated $11.6M increase.
- Invenomic Capital Management's biggest Q4 2023 reduction was Corpay, cutting an estimated $40.2M.
- Invenomic Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2023, selling an estimated $245M.
- Invenomic Capital Management's ten largest holdings make up 26% of its $2.19B portfolio in Q4 2023.
- Invenomic Capital Management opened 59 new positions and closed 32 in Q4 2023.
- Invenomic Capital Management's portfolio value fell 7.9% quarter-over-quarter to $2.19B.
Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.